George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,700 shares at $672.00 ($1.1M) on 2021-08-30, disclosed to the SEC on 2021-08-30.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $672.00 | 150 | $101K | 8.8% |
| 2 | $670.00 | 250 | $168K | 14.7% |
| 3 | $670.00 | 500 | $335K | 29.3% |
| 4 | $672.00 | 300 | $202K | 17.6% |
| 5 | $675.00 | 500 | $338K | 29.5% |
| Total | $672.00 avg | 1,700 |
| $1.1M |
| 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |